Uranium Royalty Corp (NASDAQ:UROY) does about 1.42M shares in volume on a normal day but saw 2835240 shares change hands in the recent trading day. The company now has a market cap of 315.90M USD. Its current market price is $2.60, marking a decrease of -1.14% compared to the previous close of $2.63. The 52 week high reached by this stock is $3.76 whilst the lowest price level in 52 weeks is $1.86.
Uranium Royalty Corp (UROY) has a 20-day trading average at $2.38 and the current price is -30.85% off the 52-week high compared with 39.78% distance from its 52-week low. The 50-day simple moving average of the closing price is $2.24 and its 200-day simple moving average is $2.53. If we look at the stock’s price movements over the week, volatility stands at 6.12%, which decreases to 5.45% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 64.66 to suggest the stock is neutral.
The consensus objective for the share price is $4.65, suggesting that the stock has a potential upside of 44.09% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on October 07, 2024 when B. Riley Securities initiated the stock to “Buy” and issued a price target of $3.50.
The current price level is 10.71%, 16.54%, and 2.82% away from its SMA20, SMA50, and SMA200 respectively, with the UROY price moving below the 50-day SMA on current market day. Uranium Royalty Corp (UROY) stock is up 6.12% over the week and 34.02% over the past month. Its price is -3.70% year-to-date and -10.03% over the past year.
To reach the target analysts have set, the stock logically needs to grow 44.09 percent from here.
Outstanding shares total 120.55M with insiders holding 17.26% of the shares and institutional holders owning 23.77% of the company’s common stock. The company has a return on investment of 3.88% and return on equity of 4.61%. The price to earnings ratio (P/E ratio) amounts to 39.39 while the forward price to earnings ratio is 19.61. The beta has a value of 1.50. Price to book ratio is 1.59 and price to sales ratio is 10.03.
